Search
Now showing items 1-1 of 1
(Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2019)
New therapies, including the anti‐cytotoxic T lymphocyte antigen (CTLA)‐4 antibody, ipilimumab, is approved for metastatic melanoma. Prognostic biomarkers need to be identified, because the treatment has serious side ...